BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:01 PM
 | 
Aug 22, 2012
 |  BC Extra  |  Company News

EMA begins review of Dynavax's Heplisav

Dynavax Technologies Corp. (NASDAQ:DVAX) said EMA accepted for review an MAA for Heplisav to prevent HBV infection caused by all...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >